Safety and immunogenicity of trivalent inactivated influenza vaccine in infants
about
Influenza in Infants Born to Women Vaccinated During Pregnancy.Infant Respiratory Outcomes Associated with Prenatal Exposure to Maternal 2009 A/H1N1 Influenza VaccinationProtecting young babies from influenza.Seasonal influenza immunization in early infancy?IgA and neutralizing antibodies to influenza a virus in human milk: a randomized trial of antenatal influenza immunization.Nonhuman primate infants have an impaired respiratory but not systemic IgG antibody response following influenza virus infection.Inclusion of Flagellin during Vaccination against Influenza Enhances Recall Responses in Nonhuman Primate Neonates.Live, attenuated influenza virus (LAIV) vehicles are strong inducers of immunity toward influenza B virusIncidence of Severe and Nonsevere Pertussis Among HIV-Exposed and -Unexposed Zambian Infants Through 14 Weeks of Age: Results From the Southern Africa Mother Infant Pertussis Study (SAMIPS), a Longitudinal Birth Cohort Study.Influenza vaccination among household contacts of children with cystic fibrosis and healthy children.Infants and the seasonal influenza vaccine. A global perspective on safety, effectiveness, and alternate forms of protection.Influvac, a trivalent inactivated subunit influenza vaccine.Vaccines against respiratory viral pathogens for use in neonates: opportunities and challenges.Impact of Early-Life Exposures to Infections, Antibiotics, and Vaccines on Perinatal and Long-term Health and Disease.Immunization During Pregnancy: Impact on the Infant.A Novel R848-Conjugated Inactivated Influenza Virus Vaccine Is Efficacious and Safe in a Neonate Nonhuman Primate Model.One size fits all? Antibody avidity measurement against multiple antigens in maternal vaccination studies.Adjuvanting an inactivated influenza vaccine with flagellin improves the function and quantity of the long-term antibody response in a nonhuman primate neonate model.Adjuvanting an inactivated influenza vaccine with conjugated R848 improves the level of antibody present at 6months in a nonhuman primate neonate model.The choice of linker for conjugating R848 to inactivated influenza virus determines the stimulatory capacity for innate immune cells.Prevention of influenza-related illness in young infants by maternal vaccination during pregnancy.Protéger les jeunes bébés contre la grippe.New Kids on the Block: RNA-Based Influenza Virus Vaccines.Vaccines against epidemic and pandemic influenza
P2860
Q30388726-2EC9E514-BEEB-407C-BB8E-0BF237EFD2C3Q30391418-BFA5585D-F674-4B10-A703-1E07A29FB25AQ33588918-428FA8CE-2BC4-46C5-905A-2BE3801B1EACQ34445842-72F8AFFC-5849-49FB-851D-350C1EDC0444Q34963100-4DF0BB47-CC57-47C8-AECC-EC31AD3B762EQ35070880-C511A391-8DBF-4BBD-A18E-6B842645D8EBQ35758568-108E3296-9883-4C38-B634-0461F7C05E06Q36900058-EF8F4E07-60FC-4996-B517-588465F66FF3Q37410302-1E966612-6CA7-46C2-8BAC-268973A89593Q37450549-6E9C78E6-AB1A-44AB-90E5-16FAC188E54FQ37616332-A8FADF4A-2A6E-4C7F-BBC8-9747AD9B3F03Q37812615-93A77539-3750-40AE-955E-EEBB3DC62662Q38269845-C64A82F8-772D-49B6-9926-C8453CEDB4D7Q38660625-6C759621-809A-4CC4-A459-14EB5F7435DEQ38683189-C9C04DF7-523F-442A-ACD9-536AA79B2B4DQ39698048-6EDDC0BA-2EFB-436C-A53E-4EAEF3B09529Q40238578-2DC3ED3E-DDA5-4922-9FB2-58FFF41CBC27Q40578582-AA6E5177-0046-4F71-8AE6-4B6B8F232A86Q41926881-7EA87951-2E50-4927-9CE1-1D95FBF5C9E9Q49343115-6BF6F673-C786-44B5-BEA1-7703D52A25F8Q49587453-E4AB3F0D-E466-4E45-80B0-7699CE3A55FAQ50234343-5B1E3CCC-BF80-447D-8E68-77261FF56454Q52609655-291065D1-EBE1-49DC-89F6-9E4A212F45C7Q56550815-02C2AE8D-77E5-4D44-BE50-C06D19633CF7
P2860
Safety and immunogenicity of trivalent inactivated influenza vaccine in infants
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Safety and immunogenicity of trivalent inactivated influenza vaccine in infants
@en
Safety and immunogenicity of trivalent inactivated influenza vaccine in infants.
@nl
type
label
Safety and immunogenicity of trivalent inactivated influenza vaccine in infants
@en
Safety and immunogenicity of trivalent inactivated influenza vaccine in infants.
@nl
prefLabel
Safety and immunogenicity of trivalent inactivated influenza vaccine in infants
@en
Safety and immunogenicity of trivalent inactivated influenza vaccine in infants.
@nl
P2093
P2860
P356
P1476
Safety and immunogenicity of trivalent inactivated influenza vaccine in infants
@en
P2093
Michael A Gerber
Peter F Wright
Qingxia Chen
P2860
P304
P356
10.1086/587643
P407
P577
2008-05-01T00:00:00Z